Grants for For profit organizations other than small businesses - Federal

Note: Each funding opportunity description is a synopsis of information in the Federal Register application notice. For specific information about eligibility, please see the official application notice. The official version of this document is the document published in the Federal Register. Free Internet access to the official edition of the Federal Register and the Code of Federal Regulations is available on GPO Access at: http://www.access.gpo.gov/nara/index.html. Please review the official application notice for pre-application and application requirements, application submission information, performance measures, priorities and program contact information. For the addresses for obtaining and submitting an application, please refer to our Revised Common Instructions for Applicants to Department of Education Discretionary Grant Programs, published in the Federal Register on December 23, 2024. Purpose of Program: The SEED program, authorized under section 2242 of the Elementary and Secondary Education Act of 1965, as amended (ESEA) (20 U.S.C. 6672), provides funding to increase the number of highly effective educators by supporting the implementation of evidence-based practices that prepare, develop, or enhance the skills of educators. These grants will allow eligible entities to develop, expand, and evaluate practices that can serve as models to be sustained and disseminated. Assistance Listing Number (ALN) 84.423A.

Organizations of State and Local Officials (NOSLO) Program: State Health Services and Financing to fund a national level organization with an in-depth understanding of, and experience with, providing technical assistance and support to State Medicaid Directors and other health care payment officials to assist states in leveraging HRSA programs and collaborating with Medicaid to improve access to quality health care for high need communities. Activities should include but are not limited to fostering collaborations to address maternal health disparities, bolster the health workforce, integrate behavioral health into primary care, and expand access to care for people in high need communities, such as those who live rural areas, are exiting incarceration, have HIV, and youth with unmet behavioral health needs. The successful recipient is expected to provide tailored technical assistance to State Medicaid Directors and other health care payment officials to address HRSAs priorities and maximize the benefits of and potential collaborations with HRSA programs through: Communication and information sharing between HRSA and State Medicaid Directors and other health care payment officials, and Training; data collection, sharing, and analysis; convenings, (e.g., learning exchanges on priority topics); and other activities that enable State Medicaid Directors and other health care payment officials to operate in a responsive, coordinated, and effective manner.

This funding opportunity provides financial support to organizations working to improve responses to individuals with mental health and substance use disorders within the justice system through training and technical assistance programs.

This grant provides funding for researchers to conduct innovative studies on ovarian cancer, focusing on impactful solutions that benefit patients and their families.

The Department of States Office to Monitor and Combat Trafficking in Persons (TIP Office) announces an open competition for projects in support of a forthcoming Child Protection Compact (CPC) Partnership between the United States and the Government of Romania.

The ARP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ASD. Applications are strongly encouraged to address one of the FY24 ARP Clinical Trial Award Areas of Interest. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.Research funded by the FY24 ARP should be responsive to the needs of people with ASD, their families, and/or caregivers. Researchers are therefore encouraged to establish and utilize effective collaborations and partnerships with community members to maximize the impact potential of the proposed research.CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in womens health outcomes and/or advancing knowledge for womens health.

MDF is NICs Management Development for the Future series, a dynamic, agency exclusive, individual and organizational development experience, which primarily targets the middle management tier of a correctional organization. This established curriculum simultaneously engages all levels of agency leadership through internal action-based learning strategies at the individual, team and agency levels.This agency exclusive leadership development series is conducted over up to 12+ months and is provided to participants within selected partner agencies. The learning strategies used in this blended and hybrid delivery individual and organizational development series include three phases one in person 24 - hour (3 in-person days) and two fully virtual phases (seven, 3-hour virtual instructor led sessions with intersession activities between virtual sessions), each delivered approximately 4 - 5 months apart. Participants will prepare a dynamic leadership development plan, participate in individual developmental coaching, and during intercession periods between phases undertake action-based learning projects1 Campbell, Nancy M. Correctional Leadership Competencies for the 21stCentury: Executives and Senior-Level Leaders, July 2005, Retrieved from https://s3.amazonaws.com/static.nicic.gov/Library/020474.pdf2 Day, David V., John W. Fleenor, Leanna E. Atwater, Rachel E. Sturm, and Rob A. McKee. "Advances in Leader and Leadership Development: A Review of 25 Years of Research and Theory." The Leadership Quarterly 25, no. 1 (February 2014): 63-82.3 Zenger, Jack, and Joe Folkman. "Leadership Development 6.0: Connecting Leadership Development with Drivers of Business Results." Zenger Folkman, 2010. UT: Orem24AC07focused on the relevant issues in their agencies with the intention of applying skills and strategies learned in the program to build organizational capacity and manage organizational change between phases ones, two and three. The blended and hybrid MDF series simultaneously engages all levels of agency leadership through internal action-based learning strategies at the individual, team and agency levels.Pre-session activities prior to each phase include participants completing several online instruments, reading assignments and other required activities. This program is grounded in the evidence based Full Range Leadership Model developed by Bass, B. M., and Avolio, B. J. An on-line 360-degree feedback instrument assesses the participants behavior against the model.A proposal responsive to this solicitation should provide substantiated documentation of: 1) respondent organizational capacity and project management expertise and experience to manage multiple, overlapping projects simultaneously; 2) a minimum of 10 years of experience managing national and regional training events in corrections settings; 3) 10 years of substantiated experience setting up, hosting, producing and facilitating blended (virtual instructor led platforms) and face to face training series; 4) 10 years of substantiated experience facilitating blended and face to face leader training with correctional agencies (jails, prisons, community corrections); 5) proposed faculty with 10 years minimum experience, credentials and qualifications to administer, interpret and facilitate the Multifactor Leadership Questionnaire II, FIRO-B Interpretative Report for Organizations, Thomas-Kilman Conflict Mode Indicator and other instrumentation as needed based upon partner agency needs and their applications to corrections settings; 6) 10 years experience for proposed faculty to perform developmental leadership coaching; 7) 10 years experience facilitating experiential leadership training activities and tying them through content and leadership competencies to on the job leadership correctional applications; and 8) 10 years of experience working with executive and senior level leaders in correctional agencies on organizational development initiatives which advance agencies mission, vision and values.

This funding opportunity supports early-career scientists conducting innovative research to improve the understanding, diagnosis, treatment, or prevention of mental health disorders.

The FY24 PCRP Exploration Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem relevant to one or more of the FY24 PCRP Overarching Challenges. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Results of studies conducted through this award may provide the scientific premise upon which a new hypothesis can be based or initial proof of principle of an innovative hypothesis, laying the groundwork for future avenues of scientific investigation. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described. Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborator(s), and their organization(s). Refer to Section II.D.2.b.i, Full Application Submission Type, for more information. New for FY24: Clinical research is allowed. For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes: (1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies. (2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. (3) Outcomes research and health services research that do not fit under the definition of clinical trial. Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule. Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials. A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 PCRP priorities. Innovative research involving nuclear medicine and related techniques to support early diagnosis, more-effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies. Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research. All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (https://www.nature.com/nature/ journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies. The funding instrument for awards made under the program announcement will be grants (31 USC 6304). The anticipated direct costs budgeted for the entire period of performance for an FY24 Exploration Hypothesis Development Award should not exceed $150,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. Awards supported with FY24 funds will be made no later than September 30, 2025. The CDMRP expects to allot approximately $3.60M to fund approximately 15 Exploration Hypothesis Development Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030. Research Involving Animals: All research funded by the FY24 PCRP Exploration-Hypothesis Development Award involving new and ongoing research with animals must be reviewed and approved by the USAMRDC Office of Human and Animal Research Oversight (OHARO; previously the Human Research Protection Office), Animal Care and Use Review Office (ACURO), in addition to the local Institutional Animal Care and Use Committee (IACUC) of record. IACUC approval at the time of submission is not required. Allow at least 3 to 4 months for ACURO regulatory review and approval processes for animal studies. Refer to the General Application Instructions for additional information.

The United States Agency for International Development in Vietnam (USAID/Vietnam) is seeking applications from qualified entities to implement the "USAID Reducing Pollution" activity. The overall objective of this activity is to reduce environmental pollution in targeted areas through a collective impact approach. The USAID Reducing Pollution project supports Vietnam’s efforts to address environmental pollution challenges in targeted areas through a collective impact approach. Working in close partnership with the Ministry of Natural Resources and Environment’s Vietnam Environment Administration (VEA), the project will demonstrate clear connections between environmental benefits and other social benefits, including public health, employment, and sustainable economic growth. COLLECTIVE IMPACT APPROACH A collective impact approach addresses complex challenges by mobilizing diverse actors to collaborate, identify ways to solve a shared problem, and take action based on their roles and comparative advantages. The USAID Reducing Pollution project will follow the collective impact framework to strengthen networks of local organizations, government, private sector, and academic institutions working together to prevent, mitigate, and reduce environmental pollution. SUPPORTING A PORTFOLIO OF COLLECTIVE IMPACT INITIATIVES The project will facilitate a broad consultative process with local government officials, community leaders, local organizations, and motivated businesses to identify 5-7 priority collective impact initiatives that reflect strong political will, community leadership, and engagement from private sector partners to address environmental pollution challenges. Preliminary consultations have identified air pollution and ocean plastics as areas of focus. GRANT-MAKING TO VIETNAMESE LOCAL ORGANIZATIONS To foster Vietnamese leadership in addressing environmental pollution, the project will make grants to a local organization to serve as the “backbone” for each collective impact initiative. These backbone organizations will serve as the local leaders for each initiative by building public support, advancing policy, leveraging additional funding, and designing and implementing targeted awareness and behavior change campaigns. Additional small grants to local research institutions and community-based organizations will provide targeted support for complementary research and advocacy efforts. EXPECTED RESULTS Through the Reducing Pollution project, USAID expects to attain the following results: 1) 5-7 collective impact initiatives launched, including air pollution and ocean plastics; 2) Grants awarded to one backbone organization to lead each initiative; 3) Capacity of backbone organizations and local actors strengthened to advance collective impact initiatives; 4) Sustainable funding mechanisms identified to strengthen long-term effectiveness of collective impact initiatives; and 5) New policies and guidance developed to support the 2020 Law on Environmental Protection and create a stronger enabling environment for addressing environmental pollution challenges.

To obtain a copy of the Funding Opportunity Announcement (FOA) please go to the ARPA-E website at https://arpa-e-foa.energy.gov. To apply to this FOA, Applicants must register with and submit application materials through ARPA-E eXCHANGE (https://arpa-e-foa.energy.gov/Registration.aspx). For detailed guidance on using ARPA-E eXCHANGE, please refer to the ARPA-E eXCHANGE User Guide (https://arpa-e-foa.energy.gov/Manuals.aspx). ARPA-E will not review or consider concept papers submitted through other means. For problems with ARPA-E eXCHANGE, email [email protected] (with FOA name and number in the subject line). Questions about this FOA? Check the Frequently Asked Questions available at http://arpa-e.energy.gov/faq. For questions that have not already been answered, email [email protected]. The purpose of this modification is to incorporate changes to Funding Opportunity Announcement. Accordingly, this modification: Inserted new Exploratory Topic, Topic M: H2SENSE. See Table 1. Exploratory Topics, Appendix M, and Total Amounts to be awarded on Cover Page. Updated Language in Appendix L Section 5.

Nature crimes, criminal forms of logging, mining, wildlife trade, land conversion, and associated criminal activities, as well as crimes associated with fishing, pose serious threats to the environment and to national security. They undermine the rule of law and fuel corruption. They also spread disease globally, drive species to the brink of extinction, and rob governments, indigenous peoples, and local communities of their natural resources and legitimate revenue. The goal of this program is to increase global grassroot civil society engagement in addressing nature crimes. To advance the policy goal described above, OES seeks one or two lead implementing partners to form consortia with grassroots civil society organizations across various countries to deploy community-led approaches that address global nature crime trends. By taking advantage of the valuable knowledge offered by these partners, OES aims to strengthen their efforts to expose nature crimes, hold perpetrators accountable, reduce profits from these crimes, and support the environment and local livelihoods.

This program provides training and support at no cost to small businesses, particularly those that are socially and economically disadvantaged, to help them compete for federal contracts and grow their operations.

This funding opportunity is designed to support academic and community healthcare organizations in enrolling diverse patient populations in cancer clinical trials, enhancing cancer research in underserved areas.

This funding opportunity supports junior faculty in obstetrics and gynecology who are dedicated to advancing their research careers in women's reproductive health.

This funding opportunity provides financial support to organizations and institutions working to prevent the proliferation of chemical weapons by enhancing partner nations' capabilities in detection, response, and compliance with international norms.

This funding opportunity supports research institutions and organizations in developing a comprehensive study on viral respiratory infections in young children, aiming to improve understanding and treatment of these common illnesses.

This funding opportunity supports research projects that utilize existing datasets to advance understanding of substance use disorders, targeting a wide range of eligible applicants including educational institutions, government entities, and nonprofits.

This funding opportunity supports innovative research projects aimed at improving burn care for military personnel, particularly in combat situations, by addressing unique medical challenges and enhancing treatment methods.

This funding opportunity provides financial support to early-stage postdoctoral researchers dedicated to advancing their careers in cancer research through enhanced training and mentorship.